1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Orthopedics Market Trends
  5. > North America Orthobiologics Market Outlook to 2021

North America Orthobiologics Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 226 pages

North America Orthobiologics Market Outlook to 2021

Summary

GlobalData’s new report, "North America Orthobiologics Market Outlook to 2021", provides key market data on the North America Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the North America Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

North America Orthobiologics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
2.2 Orthobiologics Market Segmentation 11
2.3 Definitions of Markets Covered in the Report 12
3 Orthobiologics Market, North America 14
3.1 Orthobiologics Market, North America, Revenue ($m), 2007-2021 14
3.2 Orthobiologics Market, North America, Category Comparison by Revenue ($m), 2007-2021 16
3.3 Orthobiologics Market, North America, Revenue ($m), 2007-2014 17
3.4 Orthobiologics Market, North America, Revenue ($m), 2014-2021 19
3.5 Orthobiologics Market, North America, Volume (Units), 2007-2021 21
3.6 Orthobiologics Market, North America, Volume (Units), 2007-2014 23
3.7 Orthobiologics Market, North America, Volume (Units), 2014-2021 25
3.8 Orthobiologics Market, North America, Company Share by Revenue ($m), 2014 27
4 Orthobiologics Market, Canada 29
4.1 Orthobiologics Market, Canada, Revenue ($m), 2007-2014 29
4.2 Orthobiologics Market, Canada, Revenue ($m), 2014-2021 31
4.2.1 Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2007-2014 33
4.2.2 Bone Grafts and Substitutes Market, Canada, Revenue ($m), by Segment, 2014-2021 35
4.3 Orthobiologics Market, Canada, Volume (Units), 2007-2014 37
4.4 Orthobiologics Market, Canada, Volume (Units), 2014-2021 39
4.4.1 Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2007-2014 41
4.4.2 Bone Grafts and Substitutes Market, Canada, Volume (Units), by Segment, 2014-2021 43
4.5 Orthobiologics Market, Canada, Average Price ($), 2007-2021 45
4.6 Orthobiologics Market, Canada, Distribution Share by Revenue ($m), 2013-2014 47
4.7 Orthobiologics Market, Canada, Company Share by Revenue ($m), 2014 48
5 Orthobiologics Market, Mexico 50
5.1 Orthobiologics Market, Mexico, Revenue ($m), 2007-2014 50
5.2 Orthobiologics Market, Mexico, Revenue ($m), 2014-2021 52
5.2.1 Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2007-2014 54
5.2.2 Bone Grafts and Substitutes Market, Mexico, Revenue ($m), by Segment, 2014-2021 56
5.3 Orthobiologics Market, Mexico, Volume (Units), 2007-2014 58
5.4 Orthobiologics Market, Mexico, Volume (Units), 2014-2021 60
5.4.1 Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2007-2014 62
5.4.2 Bone Grafts and Substitutes Market, Mexico, Volume (Units), by Segment, 2014-2021 64
5.5 Orthobiologics Market, Mexico, Average Price ($), 2007-2021 66
5.6 Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 68
5.7 Orthobiologics Market, Mexico, Company Share by Revenue ($m), 2014 69
6 Orthobiologics Market, United States 71
6.1 Orthobiologics Market, United States, Revenue ($m), 2007-2014 71
6.2 Orthobiologics Market, United States, Revenue ($m), 2014-2021 73
6.2.1 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2007-2014 75
6.2.2 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2007-2014 77
6.2.3 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2007-2014 79
6.2.4 Bone Grafts and Substitutes Market, United States, Revenue ($m), by Segment, 2014-2021 81
6.2.5 Bone Growth Stimulators Market, United States, Revenue ($m), by Segment, 2014-2021 83
6.2.6 Viscosupplementation Market, United States, Revenue ($m), by Segment, 2014-2021 85
6.3 Orthobiologics Market, United States, Volume (Units), 2007-2014 87
6.4 Orthobiologics Market, United States, Volume (Units), 2014-2021 89
6.4.1 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2007-2014 91
6.4.2 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2007-2014 93
6.4.3 Viscosupplementation Market, United States, Volume (Units), by Segment, 2007-2014 95
6.4.4 Bone Grafts and Substitutes Market, United States, Volume (Units), by Segment, 2014-2021 97
6.4.5 Bone Growth Stimulators Market, United States, Volume (Units), by Segment, 2014-2021 99
6.4.6 Viscosupplementation Market, United States, Volume (Units), by Segment, 2014-2021 101
6.5 Orthobiologics Market, United States, Average Price ($), 2007-2021 103
6.6 Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2013-2014 105
6.7 Orthobiologics Market, United States, Company Share by Revenue ($m), 2014 106
7 Overview of Key Companies in North America Orthobiologics Market 108
7.1 Medtronic plc 108
7.1.1 Company Overview 108
7.2 DePuy Companies 108
7.2.1 Company Overview 108
7.3 Sanofi 108
7.3.1 Company Overview 108
7.4 Arthrex, Inc. 109
7.4.1 Company Overview 109
7.5 Stryker Corporation 109
7.5.1 Company Overview 109
7.6 Ferring International Center S.A. 109
7.6.1 Company Overview 109
7.7 Biomet, Inc. (Inactive) 110
7.7.1 Company Overview 110
7.8 DJO Finance LLC 110
7.8.1 Company Overview 110
7.9 Bioventus LLC 110
7.9.1 Company Overview 110
7.10 Baxter International Inc. 110
7.10.1 Company Overview 110
7.11 Seikagaku Corporation 111
7.11.1 Company Overview 111
7.12 Wright Medical Group, Inc. 111
7.12.1 Company Overview 111
8 Orthobiologics Market Pipeline Products 112
9 Recent Developments 118
9.1 Corporate Communications 118
9.1.1 Aug 27, 2015: ESC Congress 2015: BIOTRONIK Announces CE Approval and Pilot Study Results for BioMonitor 2 118
9.1.2 Aug 13, 2015: Bone Biologics Appoints New Chief Executive Officer and a Chief Operating Officer 119
9.1.3 Jul 30, 2015: Histogenics Announces Appointment of Stephen Kennedy to Chief Technology Officer 120
9.1.4 Jul 15, 2015: Histogenics Announces Dr. Gloria Matthews as Chief Medical Officer 120
9.1.5 Jun 25, 2015: GenomeDx's Decipher Prostate Cancer Classifier Accurately Predicts Metastasis Ten Years after Prostate Removal in Study Published by European Urology 121
9.1.6 Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group 122
9.1.7 Jun 22, 2015: Histogenics Announces Appointment of New Chief Financial Officer 123
9.1.8 May 11, 2015: Histogenics Announces World Class Scientific Advisory Board to Support Commercialization and Pipeline Development 124
9.1.9 May 04, 2015: Mayne Pharma Update 126
9.1.10 Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine 127
9.1.11 Feb 03, 2015: U.S. FDA Grants Priority Review for YONDELIS (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma 127
9.1.12 Feb 02, 2015: Histogenics Announces the Appointment of David Gill to Its Board of Directors and Chairman of Audit Committee 128
9.1.13 Jan 14, 2015: Tissue Regeneration Systems Adds Business Development Executive 129
9.1.14 Dec 09, 2014: Bone Biologics announces appointment of George Oram to its Board of Directors 130
9.1.15 Nov 24, 2014: Alphatec Spine Announces Appointment of Tom C. Davis to Its Board of Directors 130
9.1.16 Nov 12, 2014: Bone Biologics appoints Deina Walsh CFO 130
9.1.17 Oct 10, 2014: Medtronic Announces Executive Leadership Team for Combined Organization Upon Close of Covidien Acquisition 131
9.1.18 Sep 17, 2014: Medtronic Elects Elizabeth Nabel to the Board of Directors 132
9.2 Financial Announcements 133
9.2.1 Aug 25, 2015: Entellus Medical Surpasses 100,000 Patients Treated Worldwide 133
9.2.2 Aug 22, 2015: HealthSpot disrupts the lab industry with plans to bring 7 minute blood tests to retail pharmacy clinics 134
9.2.3 Aug 12, 2015: Histogenics Announces Second Quarter 2015 Financial and Operating Results 136
9.2.4 Aug 04, 2015: Alphatec Holdings Announces Second Quarter 2015 Revenue and Financial Results 137
9.2.5 Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results 139
9.2.6 Jul 30, 2015: RTI Surgical Announces 2015 Second Quarter Results 140
9.2.7 Jul 29, 2015: Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and Continued Pipeline Progress 141
9.2.8 Jul 29, 2015: Wright Medical Group Reports 2015 Second Quarter Financial Results 142
9.2.9 Jul 28, 2015: Exactech Q2 2015 Revenue $61.5 Million. Net Income $3.7 Million. Diluted EPS $0.26. 144
9.2.10 Jul 23, 2015: Bard Announces Second Quarter Results 146
9.2.11 Jun 25, 2015: Ventripoint Announces Development of New VMS Products and Enhanced Capabilities as Featured at ASE 2015 146
9.2.12 Jun 23, 2015: Quotient Clinical begins prostate cancer project for Druggability Technologies 148
9.2.13 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 150
9.2.14 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results 153
9.2.15 May 18, 2015: Intra-Cellular Therapies Announces Further Analyses of the Phase 2 Clinical Trial of ITI-007 in Schizophrenia at the 168th Annual Meeting of the American Psychiatric Association 157
9.2.16 May 14, 2015: Histogenics Announces First Quarter 2015 Financial Results 159
9.2.17 Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results 160
9.2.18 Apr 30, 2015: Alphatec Holdings Announces First Quarter 2015 Revenue and Financial Results 161
9.2.19 Apr 29, 2015: Wright Medical Group Reports 2015 First Quarter Financial Results 163
9.2.20 Apr 28, 2015: Exactech Q1 Revenue $61.4 Million. Net Income Down 2% to $4.1 Million. Diluted EPS $0.29 vs. $0.30. 165
9.2.21 Apr 23, 2015: Bard Announces First Quarter Results 166
9.2.22 Apr 23, 2015: RTI Surgical Announces 2015 First Quarter Results 167
9.2.23 Apr 20, 2015: ALR Technologies Signs First Revenue-Generating Contract 167
9.2.24 Apr 15, 2015: Tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma 169
9.2.25 Apr 01, 2015: Idera Announces FDA Orphan Drug Designation for IMO-8400 for the Treatment of Diffuse Large B-Cell Lymphoma 171
9.2.26 Mar 11, 2015: The Medicines Company Provides new data on MDCO-216 at 2015 American College of Cardiology Scientific Sessions in San Diego 173
9.2.27 Feb 26, 2015: Histogenics Announces Fourth Quarter and Full Year 2014 Financial Results 174
9.2.28 Feb 26, 2015: Alphatec Holdings Announces Fourth Quarter and Full Year 2014 Revenue and Financial Results 175
9.2.29 Feb 25, 2015: Wright Medical Group Reports 2014 Fourth Quarter and Full-Year Financial Results and Provides 2015 Guidance 177
9.2.30 Feb 24, 2015: Integra LifeSciences Reports Fourth Quarter 2014 Financial Results 179
9.2.31 Feb 17, 2015: Exactech 2014 Revenue Up 5% to $248.4 Million, Net Income Up 7% to $16.5 Million, EPS $1.18 180
9.2.32 Feb 12, 2015: RTI Surgical Announces 2014 Fourth Quarter, Full Year Results, 2015 Financial Guidance 181
9.2.33 Jan 29, 2015: Bard Announces Fourth Quarter Results 182
9.2.34 Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine 183
9.2.35 Jan 12, 2015: Wright Medical Group Announces Preliminary Fourth Quarter and Full Year 2014 Revenue 183
9.2.36 Dec 10, 2014: Bard Declares Quarterly Dividend 184
9.2.37 Dec 04, 2014: Ra Pharmaceuticals Announces Presentation of Data Supporting Clinical Development of Novel Complement C5 Inhibitor at 2014 ASH Annual Meeting 185
9.2.38 Dec 04, 2014: Oncolytics Biotech Collaborators Present REOLYSIN and Checkpoint Inhibitor Combination Preclinical Data at AACR Tumor Immunology and Immunotherapy Conference 186
9.2.39 Dec 04, 2014: Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2015 187
9.2.40 Nov 18, 2014: Medtronic Reports Second Quarter Earnings 187
9.2.41 Nov 05, 2014: Wright Medical Group Reports 2014 Third Quarter Financial Results and Updated Guidance 189
9.2.42 Nov 03, 2014: Integra LifeSciences Reports Third Quarter 2014 Financial Results 190
9.2.43 Oct 30, 2014: Alphatec Holdings Announces Third Quarter 2014 Revenue and Financial Results 191
9.2.44 Oct 27, 2014: Wright Medical Group Announces Third Quarter 2014 Revenue 193
9.2.45 Oct 22, 2014: Two New Patents Published by the US Patent Office 193
9.2.46 Oct 22, 2014: Nuvo Research Completes WF10 U.S. Market Study for Treatment of Refractory Allergies 196
9.2.47 Oct 22, 2014: Bard Announces Third Quarter Results 197
9.2.48 Oct 21, 2014: Exactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 vs. $0.23 197
9.2.49 Oct 08, 2014: Bard Declares Regular Quarterly Dividend 198
9.2.50 Sep 16, 2014: Monarch CleanStream Evacuation System Cleaner Receives High Reviews in a Recent Peer-to-Peer Product Evaluation 198
9.3 Government and Public Interest 199
9.3.1 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 199
9.3.2 Dec 12, 2014: RTI Surgical Hosts Winter Biologics Spine Symposium 201
9.3.3 Oct 13, 2014: Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma 201
9.4 Legal And Regulatory 203
9.4.1 Jul 21, 2015: FDA Issues Warning Letter To C. R. Bard 203
9.4.2 Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas 203
9.4.3 Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures 204
9.4.4 Feb 03, 2015: MTF Announces Filing of Inter Partes Review Petitions and Motion to Stay in Patent Infringement Litigation 205
9.4.5 Jan 20, 2015: Integra LifeSciences Announces Resolution of Warning Letter Related to Its Manufacturing Facility in Anasco, Puerto Rico 205
9.5 Other Significant Developments 206
9.5.1 Jun 24, 2015: $4.5MM Verdict Reached against Wright Medical Technology says Legal-Bay Lawsuit Settlement Funding 206
9.5.2 Apr 13, 2015: RTI Surgical Announces Agreement with Novation, One of the Nation's Leading Healthcare Services Companies 206
9.5.3 Feb 27, 2015: Genzyme Recognizes International Rare Disease Day with Global Education and Fund-Raising Events; Announces Founding Partnership of Give RARE 207
9.5.4 Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants 209
9.5.5 Dec 16, 2014: Three Colorado Agencies Receive Medtronic Health Access Grant 209
9.5.6 Dec 03, 2014: Medtronic Releases 2014 Integrated Performance Report 210
9.5.7 Sep 29, 2014: Medtronic Extends Title Sponsorship of Twin Cities Marathon Through 2020 210
9.6 Strategy And Business Planning 211
9.6.1 Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine 211
9.6.2 Jun 25, 2015: The Only Permanent, FDA-Cleared, Non-Invasive Solution to Underarm Sweat, Now Available at Boston Plastic Surgery 211
9.6.3 Jun 24, 2015: LifeVac Registered With UK Ministry of Health 212
9.6.4 Dec 22, 2014: MTF forms new wound care division to meet growing medical need 213
9.6.5 Nov 03, 2014: Integra LifeSciences Announces Strategic Portfolio Alignment and Plans to Create Stand-Alone Spine Business as a Separate Public Company 214
9.6.6 Oct 17, 2014: Collagen Solutions Provides Funded Research Collaboration with Jellagen 216
9.6.7 Sep 25, 2014: Medigene to present at PIVAC Conference Rome 216
9.6.8 Sep 22, 2014: Accellent Unveils its New Brand Identity as Lake Region Medical 217
10 Appendix 218
10.1 Research Methodology 219
10.1.1 Coverage 219
10.1.2 Secondary Research 219
10.1.3 Primary Research 220
10.1.4 Market Modeling and Forecasting 221
10.1.5 Company Share Analysis 224
10.1.6 Distribution Share Analysis 225
10.2 Expert Panel 226
10.3 GlobalData Consulting 226
10.4 Contact Us 226
10.5 Disclaimer 226

1.1 List of Tables
Table 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 15
Table 2: Orthobiologics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 16
Table 3: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 18
Table 4: Orthobiologics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 20
Table 5: Orthobiologics Market, North America, Volume (Units), 2007-2021 22
Table 6: Orthobiologics Market, North America, Volume (Units), Historic, 2007-2014 24
Table 7: Orthobiologics Market, North America, Volume (Units), Forecast, 2014-2021 26
Table 8: Orthobiologics Market, North America, Company Share by Revenue ($m), USD Constant, 2014 28
Table 9: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 30
Table 10: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 32
Table 11: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 34
Table 12: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Table 13: Orthobiologics Market, Canada, Volume (Units), Historic, 2007-2014 38
Table 14: Orthobiologics Market, Canada, Volume (Units), Forecast, 2014-2021 40
Table 15: Bone Grafts and Substitutes Market, Canada, Volume (Units), Historic, 2007-2014 42
Table 16: Bone Grafts and Substitutes Market, Canada, Volume (Units), Forecast, 2014-2021 44
Table 17: Orthobiologics Market, Canada, Average Price ($) Historic, 2007-2014 45
Table 18: Orthobiologics Market, Canada, Average Price ($), Forecast, 2014-2021 46
Table 19: Orthobiologics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 47
Table 20: Orthobiologics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 49
Table 21: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 51
Table 22: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 53
Table 23: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 55
Table 24: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 57
Table 25: Orthobiologics Market, Mexico, Volume (Units), Historic, 2007-2014 59
Table 26: Orthobiologics Market, Mexico, Volume (Units), Forecast, 2014-2021 61
Table 27: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Historic, 2007-2014 63
Table 28: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Forecast, 2014-2021 65
Table 29: Orthobiologics Market, Mexico, Average Price ($) Historic, 2007-2014 66
Table 30: Orthobiologics Market, Mexico, Average Price ($), Forecast, 2014-2021 67
Table 31: Orthobiologics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014 68
Table 32: Orthobiologics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014 70
Table 33: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 72
Table 34: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 74
Table 35: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 76
Table 36: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 78
Table 37: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 80
Table 38: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 82
Table 39: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 84
Table 40: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 86
Table 41: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014 88
Table 42: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021 90
Table 43: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014 92
Table 44: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014 94
Table 45: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014 96
Table 46: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021 98
Table 47: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021 100
Table 48: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021 102
Table 49: Orthobiologics Market, United States, Average Price ($) Historic, 2007-2014 103
Table 50: Orthobiologics Market, United States, Average Price ($), Forecast, 2014-2021 104
Table 51: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 105
Table 52: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2014 107
Table 53: Orthobiologics Market Pipeline Products 112
Table 54: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 221

1.2 List of Figures
Figure 1: Orthobiologics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 14
Figure 2: Orthobiologics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 16
Figure 3: Orthobiologics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 17
Figure 4: Orthobiologics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 19
Figure 5: Orthobiologics Market, North America, Volume (Units), 2007-2021 21
Figure 6: Orthobiologics Market, North America, Volume (Units), Historic, 2007-2014 23
Figure 7: Orthobiologics Market, North America, Volume (Units), Forecast, 2014-2021 25
Figure 8: Orthobiologics Market, North America, Company Share (%) 2014 27
Figure 9: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 29
Figure 10: Orthobiologics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 31
Figure 11: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 33
Figure 12: Bone Grafts and Substitutes Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 35
Figure 13: Orthobiologics Market, Canada, Volume (Units), Historic, 2007-2014 37
Figure 14: Orthobiologics Market, Canada, Volume (Units), Forecast, 2014-2021 39
Figure 15: Bone Grafts and Substitutes Market, Canada, Volume (Units), Historic, 2007-2014 41
Figure 16: Bone Grafts and Substitutes Market, Canada, Volume (Units), Forecast, 2014-2021 43
Figure 17: Orthobiologics Market, Canada, Company Share (%) 2014 48
Figure 18: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 50
Figure 19: Orthobiologics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 52
Figure 20: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 54
Figure 21: Bone Grafts and Substitutes Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 56
Figure 22: Orthobiologics Market, Mexico, Volume (Units), Historic, 2007-2014 58
Figure 23: Orthobiologics Market, Mexico, Volume (Units), Forecast, 2014-2021 60
Figure 24: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Historic, 2007-2014 62
Figure 25: Bone Grafts and Substitutes Market, Mexico, Volume (Units), Forecast, 2014-2021 64
Figure 26: Orthobiologics Market, Mexico, Company Share (%) 2014 69
Figure 27: Orthobiologics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 71
Figure 28: Orthobiologics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 73
Figure 29: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 75
Figure 30: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 77
Figure 31: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 79
Figure 32: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 81
Figure 33: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 83
Figure 34: Viscosupplementation Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 85
Figure 35: Orthobiologics Market, United States, Volume (Units), Historic, 2007-2014 87
Figure 36: Orthobiologics Market, United States, Volume (Units), Forecast, 2014-2021 89
Figure 37: Bone Grafts and Substitutes Market, United States, Volume (Units), Historic, 2007-2014 91
Figure 38: Bone Growth Stimulators Market, United States, Volume (Units), Historic, 2007-2014 93
Figure 39: Viscosupplementation Market, United States, Volume (Units), Historic, 2007-2014 95
Figure 40: Bone Grafts and Substitutes Market, United States, Volume (Units), Forecast, 2014-2021 97
Figure 41: Bone Growth Stimulators Market, United States, Volume (Units), Forecast, 2014-2021 99
Figure 42: Viscosupplementation Market, United States, Volume (Units), Forecast, 2014-2021 101
Figure 43: Orthobiologics Market, United States, Company Share (%) 2014 106
Figure 44: GlobalData Epidemiology-Based Forecasting Model 223
Figure 45: GlobalData Capital Equipment-Based Forecasting Model 224
Figure 46: Primary Interviews by Participant Type (%) 225

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Norway Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Turkey Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others

  • $ 5995
  • Industry report
  • September 2016
  • by Global Data

Israel Orthopedic Devices Market Outlook to 2022 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.